d-Serine signalling in the brain: friend and foe

Trends in Neurosciences

Volumn 29, Issue 8, 2006, Pages 481-491

  Martineau, Magalie ^a   Baux, Gérard ^b   Mothet, Jean Pierre ^a  

^a INSERM   (France)

^b LABORATOIRE DE NEUROBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; ASPARAGINE; ASPARTIC ACID; CALCIUM ION; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXTRO SERINE; GLUTAMIC ACID; MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; POTASSIUM ION; PROTEIN KINASE C;

ASTROCYTE; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CARBOXY TERMINAL SEQUENCE; COMPARATIVE GENE MAPPING; ENCEPHALITIS; EXCITOTOXICITY; FETUS DEVELOPMENT; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; MOLECULAR BIOLOGY; MOUSE STRAIN; NEUROBIOLOGY; NEUROMODULATION; NEUROSCIENCE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; RAT STRAIN; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TREATMENT INDICATION;

ANIMALS; BRAIN; HUMANS; MODELS, BIOLOGICAL; NEUROGLIA; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE; SERINE; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 33746362592     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2006.06.008     Document Type: Review

References (96)

1. Nedergaard M., et al. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 26 (2003) 523-530
2. Ventura R., and Harris K.M. Three-dimensional relationships between hippocampal synapses and astrocytes. J. Neurosci. 19 (1999) 6897-6906
3. Haydon P.G. Glia: listening and talking to the synapse. Nat. Rev. Neurosci. 2 (2001) 185-193
4. Volterra A., and Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6 (2005) 626-640
5. Pfrieger F.W. Role of glia in synapse development. Curr. Opin. Neurobiol. 12 (2002) 486-490
6. Oliet S.H., et al. Glial modulation of synaptic transmission: Insights from the supraoptic nucleus of the hypothalamus. Glia 47 (2004) 258-267
7. Wolosker H., et al. Neurobiology through the looking-glass: d-serine as a new glial-derived transmitter. Neurochem. Int. 41 (2002) 327-332
8. Schell M.J. The N-methyl d-aspartate receptor glycine site and d-serine metabolism: an evolutionary perspective. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359 (2004) 943-964
9. Wolosker H., et al. Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-N-methyl-d-aspartate neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13409-13414
10. De Miranda J., et al. Human serine racemase: molecular cloning, genomic organization and functional analysis. Gene 256 (2000) 183-188
11. Konno R. Rat cerebral serine racemase: amino acid deletion and truncation at carboxy terminus. Neurosci. Lett. 349 (2003) 111-114
12. Xia M., et al. Characterization and localization of a human serine racemase. Mol. Brain Res. 125 (2004) 96-104
13. Williams S.M., et al. Immunocytochemical analysis of d-serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neurons. Glia 53 (2006) 401-411
14. Wu S.Z., et al. Induction of serine racemase expression and d-serine release from microglia by amyloid β-peptide. J. Neuroinflammation 1 (2004) 2
15. Wu S., and Barger S.W. Induction of serine racemase by inflammatory stimuli is dependent on AP-1. Ann. N. Y. Acad. Sci. 1035 (2004) 133-146
16. Kartvelishvily E., et al. Neuron-derived d-serine: novel means to activate N-methyl-d-aspartate receptors. J. Biol. Chem. 281 (2006) 14151-14162
17. De Miranda J., et al. Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-d-aspartate (NMDA) receptor coagonist d-serine. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14542-14547
18. Neidle A., and Dunlop D.S. Allosteric regulation of mouse brain serine racemase. Neurochem. Res. 27 (2002) 1719-1724
19. Foltyn V.N., et al. Serine racemase modulates intracellular d-serine levels through an α,β-elimination activity. J. Biol. Chem. 280 (2005) 1754-1763
20. Cook S.P., et al. Direct calcium binding results in activation of brain serine racemase. J. Biol. Chem. 277 (2002) 27782-27792
21. Dunlop D.S., and Neidle A. Regulation of serine racemase activity by amino acids. Mol. Brain Res. 133 (2005) 208-214
22. Strisovsky K., et al. Dual substrate and reaction specificity in mouse serine racemase: identification of high-affinity dicarboxylate substrate and inhibitors and analysis of the β-eliminase activity. Biochemistry 44 (2005) 13091-13100
23. Kim P.M., et al. Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2105-2110
24. Zhou M., and Kimelberg H.K. Freshly isolated hippocampal CA1 astrocytes comprise two populations differing in glutamate transporter and AMPA receptor expression. J. Neurosci. 21 (2001) 7901-7908
25. Fujii K., et al. Serine racemase binds to PICK1: potential relevance to schizophrenia. Mol. Psychiatry 11 (2006) 150-157
26. Strisovsky K., et al. Mouse brain serine racemase catalyzes specific elimination of l-serine to pyruvate. FEBS Lett. 535 (2003) 44-48
27. Schell M.J., et al. d-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3948-3952
28. Moreno S., et al. Immunocytochemical localization of d-amino acid oxidase in rat brain. J. Neurocytol. 28 (1999) 169-185
29. Urai Y., et al. Gene expression of d-amino acid oxidase in cultured rat astrocytes: regional and cell type specific expression. Neurosci. Lett. 324 (2002) 101-104
30. Hamase K., et al. Sensitive determination of d-amino acids in mammals and the effect of d-amino-acid oxidase activity on their amounts. Biol. Pharm. Bull. 28 (2005) 1578-1584
31. Shoji K., et al. Regulation of serine racemase activity by d-serine and nitric oxide in human glioblastoma cells. Neurosci. Lett. 392 (2006) 75-78
32. Shoji K., et al. Mutual regulation between serine and nitric oxide metabolism in human glioblastoma cells. Neurosci. Lett. 394 (2006) 163-167
33. Boehning D., and Snyder S.H. Novel neural modulators. Annu. Rev. Neurosci. 26 (2003) 105-131
34. Ciriacks C.M., and Bowser M.T. Measuring the effect of glutamate receptor agonists on extracellular d-serine concentrations in the rat striatum using online microdialysis-capillary electrophoresis. Neurosci. Lett. 393 (2006) 200-205
35. Mothet J.P., et al. Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter d-serine. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5606-5611
36. Coco S., et al. Storage and release of ATP from astrocytes in culture. J. Biol. Chem. 278 (2003) 1354-1362
37. Bezzi P., et al. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat. Neurosci. 7 (2004) 613-620
38. Ribeiro C.S., et al. Glial transport of the neuromodulator d-serine. Brain Res. 929 (2002) 202-209
39. Verkhratsky A., et al. Glial calcium: homeostasis and signaling function. Physiol. Rev. 78 (1998) 99-141
40. Hayashi F., et al. Uptake of d- and l-serine in C6 glioma cells. Neurosci. Lett. 239 (1997) 85-88
41. Yamamoto N., et al. Uptake of d-serine by synaptosomal P2 fraction isolated from rat brain. Synapse 42 (2001) 84-86
42. Javitt D.C., et al. A novel alanine-insensitive d-serine transporter in rat brain synaptosomal. Brain Res. 941 (2002) 146-149
43. O'Brien K.B., et al. d-Serine uptake by isolated retinas is consistent with ASCT-mediated transport. Neurosci. Lett. 385 (2005) 58-63
44. Xie X., et al. Lack of the alanine-serine-cysteine transporter 1 causes tremors, seizures, and early postnatal death in mice. Brain Res. 1052 (2005) 212-221
45. Helboe L., et al. Distribution and pharmacology of alanine-serine-cysteine transporter 1 (ASC-1) in rodent brain. Eur. J. Neurosci. 18 (2003) 2227-2238
46. Matsuo H., et al. High affinity d- and l-serine transporter ASC-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices. Neurosci. Lett. 358 (2004) 123-126
47. Schell M.J., et al. d-Serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J. Neurosci. 17 (1997) 1604-1615
48. Nicoll R.A. Expression mechanisms underlying long-term potentiation: a postsynaptic view. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358 (2003) 721-726
49. Yang Y., et al. Contribution of astrocytes to hippocampal long-term potentiation through release of d-serine. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15194-15199
50. Barnes C.A. Long-term potentiation and the ageing brain. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358 (2003) 765-772
51. Yang S., et al. d-serine enhances impaired long-term potentiation in CA1 subfield of hippocampal slices from aged senescence-accelerated mouse prone/8. Neurosci. Lett. 379 (2005) 7-12
52. Mothet J.P., et al. A critical role for the glial-derived neuromodulator d-serine in the age-related deficits of cellular mechanisms of learning and memory. Aging Cell 5 (2006) 267-274
53. Wake K., et al. Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-d-aspartate receptor-mediated synaptic transmission in mutant mice lacking d-amino-acid oxidase. Neurosci. Lett. 297 (2001) 25-28
54. Mothet J.P., et al. d-serine is an endogenous ligand for the glycine site of the N-methyl- d -aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4926-4931
55. Stevens E.R., et al. d-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6789-6794
56. Dememes D., et al. Cellular distribution of d-serine, serine racemase and d-amino acid oxidase in the rat vestibular sensory epithelia. Neuroscience 137 (2006) 991-997
57. Nakajima K., et al. Neurotrophin secretion from cultured microglia. J. Neurosci. Res. 65 (2001) 322-331
58. Hatten M.E. Central nervous system neuronal migration. Annu. Rev. Neurosci. 22 (1999) 511-539
59. Yacubova E., and Komuro H. Cellular and molecular mechanisms of cerebellar granule cell migration. Cell Biochem. Biophys. 37 (2003) 213-234
60. Hepner F., et al. Mass spectrometrical analysis of human serine racemase in foetal brain. J. Neural Transm. 112 (2005) 805-811
61. Chen Z., et al. Serine racemase and d-serine transport in human placenta and evidence for a transplacental gradient for d-serine in humans. J. Soc. Gynecol. Investig. 11 (2004) 294-303
62. Ritter L.M., et al. Ontogeny of ionotropic glutamate receptor expression in human fetal brain. Dev. Brain Res. 127 (2001) 123-133
63. Reiprich P., et al. Neonatal NMDA receptor blockade disturbs neuronal migration in rat somatosensory cortex in vivo. Cereb. Cortex 15 (2005) 349-358
64. Gressens P. Mechanisms and disturbances of neuronal migration. Pediatr. Res. 48 (2000) 725-730
65. Taharaguchi S., et al. Impaired development of the cerebellum in transgenic mice expressing the immediate-early protein IE180 of pseudorabies virus. Virology 307 (2003) 243-254
66. Hardingham G.E., and Bading H. The Yin and Yang of NMDA receptor signalling. Trends Neurosci. 26 (2003) 81-89
67. Kemp J.A., and McKernan R.M. NMDA receptor pathways as drug targets. Nat. Neurosci. 5 (2002) 1039-1042
68. Lipton S.A. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx 1 (2004) 101-110
69. Rao S.D., et al. Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons. J. Neurosci. 23 (2003) 2627-2633
70. Takano T., et al. Glutamate release promotes growth of malignant gliomas. Nat. Med. 7 (2001) 1010-1015
71. Aschner M., et al. Glial cells in neurotoxicity development. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 151-173
72. Swanson R.A., et al. Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 4 (2004) 193-205
73. Butterfield D.A., and Boyd-Kimball D. Amyloid β-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol. 14 (2004) 426-432
74. Barger S.W., and Basile A.S. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J. Neurochem. 76 (2001) 846-854
75. Silei V., et al. Activation of microglial cells by PrP and β-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels. Brain Res. 818 (1999) 168-170
76. Fisher G., et al. Free d- and l-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects. Amino Acids 15 (1998) 263-269
77. Nagata Y., et al. Free d-serine concentration in normal and Alzheimer human brain. Brain Res. Bull. 38 (1995) 181-183
78. Hashimoto K., et al. Possible role of d-serine in the pathophysiology of Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 385-388
79. Bonny C., et al. Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases. Rev. Neurosci. 16 (2005) 57-67
80. Gao Y., et al. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J. Cereb. Blood Flow Metab. 25 (2005) 694-712
81. Yoshikawa M., et al. Acute treatment with morphine augments the expression of serine racemase and d-amino acid oxidase mRNAs in rat brain. Eur. J. Pharmacol. 525 (2005) 94-97
82. Doya H., et al. c-Jun N-terminal kinase activation in dorsal root ganglion contributes to pain hypersensitivity. Biochem. Biophys. Res. Commun. 335 (2005) 132-138
83. Katsuki H., et al. Endogenous d-serine is involved in induction of neuronal death by N-methyl-d-aspartate and simulated ischemia in rat cerebrocortical slices. J. Pharmacol. Exp. Ther. 311 (2004) 836-844
84. Shleper M., et al. d-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices. J. Neurosci. 25 (2005) 9413-9417
85. Chumakov I., et al. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13675-13680
86. Owen M.J., et al. Schizophrenia: genes at last?. Trends Genet. 21 (2005) 518-525
87. Martina M., et al. Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice. J. Physiol. 563 (2005) 777-793
88. Prybylowski K., and Wenthold R.J. N-Methyl-d-aspartate receptors: subunit assembly and trafficking to the synapse. J. Biol. Chem. 279 (2004) 9673-9676
89. Cull-Candy S., et al. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11 (2001) 327-335
90. Foucaud B., et al. Structural model of the N-methyl-d-aspartate receptor glycine site probed by site-directed chemical coupling. J. Biol. Chem. 278 (2003) 24011-24017
91. Furukawa H., and Gouaux E. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J. 22 (2003) 2873-2885
92. Inanobe A., et al. Mechanism of partial agonist action at the NR1 subunit of NMDA receptors. Neuron 47 (2005) 71-84
93. Das S., et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393 (1998) 377-381
94. Johnson J.W., and Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325 (1987) 529-531
95. Kleckner N.W., and Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241 (1988) 835-837
96. Rossi D.J., and Slater N.T. The developmental onset of NMDA receptor-channel activity during neuronal migration. Neuropharmacology 32 (1993) 1239-1248